Pfizer
Angelo Beltotti has extensive experience in the pharmaceutical industry, specifically with Pfizer since November 1992, where Angelo currently serves as Senior Director of Product Launch Excellence and Team Lead, alongside a role as Senior Director of Visual Inspection and Packaging. In these roles, Angelo leads initiatives in visual inspection, labeling, and packaging for aseptic vials and syringes, focusing on operational excellence and lean manufacturing practices. Previous positions include Site Leader for Carlisle Operations, where output was doubled, and Site Leader in Soborg, Denmark, overseeing a successful site closure and product transfer program. Earlier in their career, Angelo held multiple positions at Pall Corporation from December 1988 to November 1992, culminating as Maintenance Manager. Angelo holds a degree from Stony Brook University, earned between 1984 and 1988.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.